Logis Mon, Inc. (XKON:223220)

Theseus Pharmaceuticals Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2014
Period Ending	Dec 31, 2014
Cash & Equivalents	6,810
Cash & Short-Term Investments	6,810
Accounts Receivable	1,731
Other Receivables	192.33
Receivables	1,924
Prepaid Expenses	1,464
Other Current Assets	1,184
Total Current Assets	11,381
Property, Plant & Equipment	43.84
Long-Term Investments	-0
Other Intangible Assets	1,143
Long-Term Deferred Tax Assets	241.04
Other Long-Term Assets	528.6
Total Assets	13,338
Accrued Expenses	267.63
Current Income Taxes Payable	495.86
Current Unearned Revenue	451.85
Other Current Liabilities	9,335
Total Current Liabilities	10,551
Other Long-Term Liabilities	-0
Total Liabilities	10,628
Common Stock	1,700
Retained Earnings	917.73
Comprehensive Income & Other	91.34
Shareholders' Equity	2,709
Total Liabilities & Equity	13,338
Net Cash (Debt)	6,810
Net Cash Per Share	20029.65
Filing Date Shares Outstanding	0.34
Total Common Shares Outstanding	0.34
Working Capital	829.96
Book Value Per Share	7968.40
Tangible Book Value	1,566
Tangible Book Value Per Share	4605.56
Machinery	56.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.